A security analysis is not yet prepared for this market.
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Gossamer Bio, Inc. (GOSS) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Gossamer Bio, Inc. (GOSS) on November 18, 2026 is $11.38, +3.12% on the day. Market capitalisation is $44.06 million, rank 260 among 379 stocks of the same industry with a known capitalisation.
Gossamer Bio, Inc. trades on Nasdaq under the ticker GOSS. The company belongs to the Health care sector. The trading history on this page starts on 8 February 2019.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.8, below the sector median of 3.5. Calculated from reports for the period ending 30 June 2026.
Gossamer Bio, Inc. reported revenue of $53M and a net loss of $125M over the last four quarters. Net margin is −235.00%. Revenue changed by +32.43% year over year. Earnings per share are −$52.80. Market capitalisation is $44M.